124 related articles for article (PubMed ID: 21276878)
1. Mathematical model to predict risk for lymphoedema after treatment of cutaneous melanoma.
Campanholi LL; Duprat Neto JP; Fregnani JH
Int J Surg; 2011; 9(4):306-9. PubMed ID: 21276878
[TBL] [Abstract][Full Text] [Related]
2. Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis.
Spillane AJ; Saw RP; Tucker M; Byth K; Thompson JF
Ann Surg; 2008 Aug; 248(2):286-93. PubMed ID: 18650640
[TBL] [Abstract][Full Text] [Related]
3. Inguinal lymphadenectomy for stage III melanoma: a comparative study of two surgical approaches at the onset of lymphoedema.
Bertheuil N; Sulpice L; Levi Sandri GB; Lavoué V; Watier E; Meunier B
Eur J Surg Oncol; 2015 Feb; 41(2):215-9. PubMed ID: 25524886
[TBL] [Abstract][Full Text] [Related]
4. [Leg swelling following inguinal and ilioinguinal dissection of melanoma metastases].
Pratsch AL; Kretschmer L
Zentralbl Chir; 2014 Dec; 139 Suppl 2():e83-9. PubMed ID: 22511022
[TBL] [Abstract][Full Text] [Related]
5. [Surgical technique and postoperative morbidity following radical inguinal/iliacal lymph node dissection--a prospective study in 67 patients with malignant melanoma metastatic to the groin].
Mall JW; Reetz C; Koplin G; Schäfer-Hesterberg G; Voit C; Neuss H
Zentralbl Chir; 2009 Sep; 134(5):437-42. PubMed ID: 19757344
[TBL] [Abstract][Full Text] [Related]
6. [Indications for prophylactic lymphadenectomy in skin melanoma of the lower limbs].
Vagner RI; Anisimov VV
Vopr Onkol; 1986; 32(12):13-8. PubMed ID: 3798833
[TBL] [Abstract][Full Text] [Related]
7. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
8. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma.
de Vries M; Vonkeman WG; van Ginkel RJ; Hoekstra HJ
Eur J Surg Oncol; 2006 Sep; 32(7):785-9. PubMed ID: 16806794
[TBL] [Abstract][Full Text] [Related]
9. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.
Allan CP; Hayes AJ; Thomas JM
ANZ J Surg; 2008 Nov; 78(11):982-6. PubMed ID: 18959697
[TBL] [Abstract][Full Text] [Related]
10. Surgical wound complications after groin dissection in melanoma patients - a historical cohort study and risk factor analysis.
Stuiver MM; Westerduin E; ter Meulen S; Vincent AD; Nieweg OE; Wouters MW
Eur J Surg Oncol; 2014 Oct; 40(10):1284-90. PubMed ID: 24612654
[TBL] [Abstract][Full Text] [Related]
11. Is there increased risk of local and in-transit recurrence following sentinel lymph node biopsy?
Cerovac S; Mashhadi SA; Williams AM; Allan RA; Stanley PR; Powell BW
J Plast Reconstr Aesthet Surg; 2006; 59(5):487-93. PubMed ID: 16631558
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema.
Gjorup CA; Groenvold M; Hendel HW; Dahlstroem K; Drzewiecki KT; Klausen TW; Hölmich LR
Eur J Cancer; 2017 Nov; 85():122-132. PubMed ID: 28918186
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy.
Morris KT; Busam KJ; Bero S; Patel A; Brady MS
Ann Surg Oncol; 2008 Jan; 15(1):316-22. PubMed ID: 18004626
[TBL] [Abstract][Full Text] [Related]
14. Oncologic outcomes of patients undergoing videoscopic inguinal lymphadenectomy for metastatic melanoma.
Martin BM; Etra JW; Russell MC; Rizzo M; Kooby DA; Staley CA; Master VA; Delman KA
J Am Coll Surg; 2014 Apr; 218(4):620-6. PubMed ID: 24560569
[TBL] [Abstract][Full Text] [Related]
15. Complications following inguinal and ilioinguinal lymphadenectomies: a meta-analysis.
Söderman M; Thomsen JB; Sørensen JA
J Plast Surg Hand Surg; 2016 Dec; 50(6):315-320. PubMed ID: 27146716
[TBL] [Abstract][Full Text] [Related]
16. Leg Lymphoedema After Inguinal and Ilio-Inguinal Lymphadenectomy for Melanoma: Results from a Prospective, Randomised Trial.
Lee TS; Li I; Peric B; Saw RPM; Duprat JP; Bertolli E; Spillane JB; van Leeuwen BL; Moncrieff M; Sommariva A; Allan CP; de Wilt JHW; Jones RP; Geh JLC; Howle JR; Spillane AJ
Ann Surg Oncol; 2024 Jun; 31(6):4061-4070. PubMed ID: 38494565
[TBL] [Abstract][Full Text] [Related]
17. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma.
Kretschmer L; Beckmann I; Thoms KM; Mitteldorf C; Bertsch HP; Neumann C
Ann Surg Oncol; 2006 Aug; 13(8):1105-12. PubMed ID: 16865591
[TBL] [Abstract][Full Text] [Related]
19. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.
Hughes TM; A'Hern RP; Thomas JM
Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025
[TBL] [Abstract][Full Text] [Related]
20. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.
Lee JH; Essner R; Torisu-Itakura H; Wanek L; Wang H; Morton DL
J Clin Oncol; 2004 Sep; 22(18):3677-84. PubMed ID: 15365064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]